Tehran University of Medical Sciences
Office of Vice-Chancellor for Global Strategies & International Affairs
International Human Capacity Development (IHCD)
Code : 9345-358873      Publish Date : Wednesday, March 6, 2024 Visit : 41

Intl. Congress form | International Congress Report | International Congress Report For Faculty | The report of European Academy of Dermatology and Venereology by Dr. Hamidreza Mahmoudi

The report of European Academy of Dermatology and Venereology by Dr. Hamidreza Mahmoudi
The report of European Academy of Dermatology and Venereology by Dr. Hamidreza Mahmoudi

 Application Code :

762-0223-0052
 
Created Date : Sunday, September 3, 2023-23:03 23:03:45Update Date : Sunday, December 31, 2023-10:51 10:51:32
IP Address : 94.182.182.30Submit Date : Sunday, December 31, 2023-10:51 10:51:39Email : hrmdmg.mahmoudi@yahoo.com
International Congress Form (for Faculty Members)
Personal Information

 

 
Name: : Hamidreza
Surname: : Mahmoudi
School/Research Center: : School of Medicine
Department : Dermatology
Position: : Associate professor

 
The Abstract that you e-mailed to the Congress Secretary: : https://gsia.tums.ac.ir/images/UserFiles/81123/Forms/762/Scleromyxedema summary_1.pdf
The Acceptance that is e-mailed from the Congress Secretary: : https://gsia.tums.ac.ir/images/UserFiles/81123/Forms/762/Message_1.pdf
The presentation: : Oral
Title of the Congress: : European Academy of Dermatology and Venereology
Title of your Abstract: : Skleromyxedema - treatment options and comorbities
Destination Country: : Germany
From: : Wednesday, October 11, 2023
   
To: : Saturday, October 14, 2023
   

 
Please give a briefing of your own observations and outcomes of the congress : I gave my presentation about Scleromyxedema in a session about sclerodermoid disorders. The session was very challenging and the interaction rate of the audience was high. I also made some connections with other speakers in order to collaborate and run new international studies.
Your observations and outcomes : The congress was very updated and I learned new things which I can use in my further research and also in the treatment of my patients.I gave my presentation about Scleromyxedema in a session about sclerodermoid disorders. The session was very challenging and the interaction rate of the audience was high. I also made some connections with other speakers in order to collaborate and run new